Freedom Investment Management Inc. lessened its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 18.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,118 shares of the financial services provider’s stock after selling 725 shares during the period. Freedom Investment Management Inc.’s holdings in CME Group were worth $688,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in CME. Wealth Enhancement Advisory Services LLC grew its position in shares of CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after buying an additional 8,443 shares during the last quarter. Cetera Investment Advisers increased its position in shares of CME Group by 429.1% during the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after purchasing an additional 38,540 shares in the last quarter. Brookstone Capital Management increased its position in shares of CME Group by 12.2% during the second quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock worth $6,156,000 after purchasing an additional 3,325 shares in the last quarter. Mather Group LLC. lifted its holdings in shares of CME Group by 197.2% during the 2nd quarter. Mather Group LLC. now owns 6,066 shares of the financial services provider’s stock valued at $1,306,000 after purchasing an additional 4,025 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. lifted its holdings in shares of CME Group by 40.8% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 10,742 shares of the financial services provider’s stock valued at $2,112,000 after purchasing an additional 3,112 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 5.38 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. The trade was a 14.26 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,028 shares of company stock worth $1,811,681. Company insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on CME
CME Group Stock Up 1.3 %
Shares of CME opened at $237.33 on Friday. The company has a market capitalization of $85.52 billion, a price-to-earnings ratio of 24.96, a PEG ratio of 5.29 and a beta of 0.55. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $238.12. The stock’s 50-day moving average price is $225.05 and its 200-day moving average price is $211.73. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.25 EPS. On average, sell-side analysts predict that CME Group Inc. will post 10.22 EPS for the current year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 1.94%. CME Group’s payout ratio is 48.37%.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Use the MarketBeat Excel Dividend Calculator
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Best Aerospace Stocks Investing
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.